Level of evidence for FDA drug approvals in pivotal clinical trials of hematological malignancies-Reference-Cited by-同舟云学术

Level of evidence for FDA drug approvals in pivotal clinical trials of hematological malignancies

Published:2021-01-24 Issue:6 Volume:62 Page:1522-1524
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Al Hadidi Samer¹,Ramos Carlos Almeida¹

Affiliation:

1. Department of Hematology and Oncology, The Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1876872

Reference9 articles.

1. Lls.org [Internet]. New York: Leukemia and Lymphoma Society, 2020; [cited 2020 Oct 22]. Available from: https://www.lls.org/blog/recent-drug-approvals-for-blood-cancer-mark-significant-progress-for-patients

2. Participation of African American Persons in Clinical Trials Supporting U.S. Food and Drug Administration Approval of Cancer Drugs

3. Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm

4. The power of comparative studies

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scenario analysis and multi-criteria decision analysis to explore alternative reimbursement pathways for whole genome sequencing for blood cancer patients;Journal of Cancer Policy;2024-09

2. Molecular Mechanisms of Immune Checkpoints as an Immunotherapy Tool in Hematological Malignancies;Reference Module in Biomedical Sciences;2024

3. Design, power, and alpha levels in randomized phase II oncology trials;ESMO Open;2023-02

4. Characteristics of clinical trials for haematological malignancies from 2015 to 2020: A systematic review;European Journal of Cancer;2022-05

5. Robustness and pragmatism of the evidence supporting the European Society for Medical Oncology guidelines for the diagnosis, treatment, and follow-up of follicular lymphoma;Expert Review of Hematology;2021-07-03